What are the treatment options for glaucoma, including medical, laser, and surgical interventions?

How Glaucoma is Treated

The primary goal of glaucoma treatment is to lower intraocular pressure (IOP) through a stepwise approach: starting with topical medications (prostaglandin analogs first-line), progressing to laser therapy (selective laser trabeculoplasty), and ultimately surgical intervention when needed to prevent irreversible vision loss. 1

Medical Therapy: First-Line Treatment

Topical ocular hypotensive medications form the foundation of glaucoma management. The evidence demonstrates that lowering IOP reduces the risk of visual field progression in open-angle glaucoma 1. Multiple large trials show that:

• Prostaglandin analogs (like latanoprost) are most effective, reducing IOP by approximately 25-38% and significantly reducing visual field deterioration risk (hazard ratio 0.44) 1
• Beta-adrenergic antagonists
• Alpha2-adrenergic agonists
• Carbonic anhydrase inhibitors (topical, oral, or intravenous)
• Parasympathomimetics

Newer sustained-release drug delivery systems include bimatoprost implants (lasting ~1 year) and travoprost implants (lasting ~3 years), which improve adherence by eliminating daily drop burden 2.

Critical Pitfall

IOP reduction effectiveness varies dramatically by individual. Studies show that 25-71% of patients with IOP >21 mmHg do NOT have glaucomatous damage, highlighting that there is no universal "safe" IOP cutoff 1. Treatment must be individualized based on optic nerve susceptibility and progression risk.

Laser Therapy: Second-Line or Alternative First-Line

Selective laser trabeculoplasty (SLT) has gained acceptance as either adjunctive therapy or primary treatment in mild open-angle glaucoma 3. The evidence shows:

• Achieves 30-38% IOP reduction 1
• Less effective than trabeculectomy but safer
• Direct selective laser trabeculoplasty (DSLT) is newly FDA-approved, applying laser through the limbus in just 2 seconds 2

For angle-closure glaucoma, laser peripheral iridotomy (LPI) is the definitive treatment to relieve pupillary block 4.

Surgical Intervention: When Medical/Laser Therapy Fails

Surgery becomes necessary when target IOP cannot be achieved with medications and laser, or in advanced disease. The hierarchy of evidence shows:

Traditional Surgery

Trabeculectomy remains the gold standard, demonstrating:

• 46-60% IOP reduction (superior to medical therapy's 38-42% reduction) 1
• Significantly less visual field deterioration compared to medical therapy alone
• Racial differences matter: African descent patients do better with laser trabeculoplasty first (30% reduction), while Caucasians benefit more from trabeculectomy long-term (48% reduction) 1

Minimally Invasive Glaucoma Surgery (MIGS)

MIGS procedures are increasingly used as safer alternatives, particularly when combined with cataract extraction 3, 5. These include:

• Supraciliary stents
• Schlemm's canal devices
• Suprachoroidal approaches
• Goniotomy techniques (especially valuable in resource-limited settings) 3

Cataract Extraction

For angle-closure glaucoma specifically, cataract extraction alone can substantially lower IOP in PAC and PACG patients and should be considered as a treatment option 4.

Special Considerations for Acute Angle-Closure Crisis

In acute angle-closure crisis (AACC), treatment follows a specific algorithm 4:

1. Immediate medical therapy to lower IOP and clear corneal edema:

   • Topical beta-blockers and alpha-agonists
   • Carbonic anhydrase inhibitors (topical/oral/IV)
   • Hyperosmotic agents (oral/IV) for rapid IOP reduction
   • Parasympathomimetics (though may be ineffective if IOP markedly elevated due to sphincter ischemia)

2. Laser peripheral iridotomy performed as soon as possible (preferred over surgical iridectomy due to favorable risk-benefit ratio)

3. IOP monitoring within 30 minutes to 2 hours post-procedure 4

4. Postoperative topical corticosteroids 4

Critical Pitfall in Angle-Closure

If IOP remains elevated after iridotomy, consider: trabecular damage from prior angle closure, iridotomy occlusion, plateau iris syndrome, or superimposed open-angle glaucoma. Additional management then mirrors open-angle glaucoma treatment 4.

Emerging Technologies

Novel FDA-approved devices include 2:

• Ocular pressure adjusting pump: Non-invasive goggles using negative pressure to lower IOP
• Adjustable aqueous tube shunts (under review)

Treatment Algorithm Summary

For open-angle glaucoma:

1. Start prostaglandin analog drops (or consider SLT as first-line in mild disease)
2. Add second/third topical agents or perform SLT if inadequate response
3. Consider sustained-release implants for adherence issues
4. Proceed to MIGS if combined with cataract surgery
5. Trabeculectomy for advanced disease or when other measures fail

For angle-closure disease:

1. Laser peripheral iridotomy to relieve pupillary block
2. If IOP remains elevated, treat as open-angle glaucoma
3. Consider cataract extraction as therapeutic intervention

The lowest IOP group in advanced glaucoma (47% reduction) showed no further visual field deterioration, emphasizing that aggressive IOP lowering prevents progression 1.